GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Olink Holding AB (NAS:OLK) » Definitions » Total Receivables

Olink Holding AB (Olink Holding AB) Total Receivables : $76.1 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Olink Holding AB Total Receivables?

Olink Holding AB's Total Receivables for the quarter that ended in Dec. 2023 was $76.1 Mil.


Olink Holding AB Total Receivables Historical Data

The historical data trend for Olink Holding AB's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olink Holding AB Total Receivables Chart

Olink Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Receivables
18.81 37.83 53.63 63.09 76.07

Olink Holding AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.09 37.39 40.74 61.73 76.07

Olink Holding AB Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Olink Holding AB Total Receivables Related Terms

Thank you for viewing the detailed overview of Olink Holding AB's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Olink Holding AB (Olink Holding AB) Business Description

Traded in Other Exchanges
Address
Uppsala Science Park, Uppsala, SWE, SE-75183
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the Americas, China, EMEA (Excluding Sweden) Japan, and other regions.